CG Oncology’s $120 Million Series E Financing Round

Laura Testa
Tagged:

Latham & Watkins LLP represented CG Oncology in the transaction.CG Oncology, Inc., an oncolytic immunotherapy company focused on developing novel therapeutics for patients with urologic cancers,…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now